← 產業報告目錄

Biopsy Devices Market by Product (Core needle biopsy (Automatic, Disposable), Technology (Ultrasound,stereotactic), Application (Oncology, Gastroenterology, Bone & Bone marrow biopsy), End User (Diagnostic imaging centres) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-03-03頁數 504報告編號 BT5504

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global biopsy device market is projected to reach USD 11.01 billion by 2030 from USD 7.27 billion in 2024, at a CAGR of 7.2% during the forecast period.” One of the biggest drivers is the growing incidence of cancer, especially breast, lung, and prostate cancers, which need precise and early diagnostic tests. The World Health Organization states that cancer cases are likely to increase substantially by 2030. Therefore, there would be an increasing demand for biopsy devices. Also, the growing demand for less invasive procedures is driving market growth further. The newer biopsy methods like vacuum-assisted and liquid biopsies are more accurate, have lower recovery times, and cause lower patient discomfort Furthermore, advances in technology, such as robotic-assisted biopsy machines, AI-based diagnostic systems, and image-guided biopsy procedures, improve accuracy and efficiency, driving market growth further. Moreover, rising government programs for cancer screening, combined with rising healthcare spending, especially in developing nations, drive the market forward. Nonetheless, the high prices of sophisticated biopsy devices and strict regulatory environments can serve as constraints. “The needle-based biopsy instrument segment to grow the fastest during the forecast period.” Based on the product, the biopsy device market is divided into Needle-based biopsy instrument, Visualization device, Brush biopsy instrument, Biopsy accessory and Robotic biopsy device. Among these, in 2023, Needle-based biopsy instrument segment account for the highest growing segment of 7.8% in biopsy device market. This is due to rising preference for the utilization of minimally invasive diagnostic interventions. The Needle biopsy devices such as core needle biopsy (CNB), fine needle aspiration biopsy (FNAB), and vacuum-assisted biopsy (VAB) devices provide a less painful and less invasive alternative to surgical biopsies. This lowers patient pain, recovery time, and procedural expenses. Moreover, the growing focus on early disease detection and precision medicine has also driven demand for needle biopsies, as they yield very accurate tissue samples with few complications. Further, the increasing trend towards ambulatory and outpatient facilities for biopsies has also increased the market, as needle biopsies are quick and require little infrastructure. However, the risks of bleeding, infection, and sampling errors pose challenges to the growth of this market. “The gastroenterology segment accounts for the second largest market share in biopsy device market.” Based on application, the biopsy device market is segmented into oncology, Gastroenterology, Bone & Bone marrow biopsy and other applications. The gastroenterology segment accounts for the second largest market share in biopsy device market. This can be attributed to the growing cased of gastrointestinal (GI) diseases and technological advancements in endoscopic biopsy methods. Moreover, the GI disorders such as Colorectal cancer, gastric cancer, inflammatory bowel disease (IBD), celiac disease, and gastrointestinal infections need biopsy procedures for proper diagnosis. Further, the increasing incidence of colorectal cancer, one of the most recurrently diagnosed cancers globally, makes a major contribution to the need for GI biopsy devices. Furthermore, the growing use of image-guided biopsy methods, namely endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and fine-needle biopsy (EUS-FNB), improves diagnostic accuracy in deep-seated GI tumors, contributing to market growth. Moreover, rise in geriatric population suffering from GI disorders and advancements in healthcare infrastructure on a worldwide level favour market growth. “Asia Pacific accounted for the fastest growing of the biopsy device market by region.” The global biopsy device market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is the fastest growing regional market for the biopsy device and is estimated to grow at the highest CAGR during the forecast period. The increasing incidence of cancer, coupled by demographic changes and lifestyle factors, has increased the need for early diagnosis, driving the use of biopsy procedures. Development of healthcare infrastructure, especially in nations such as China, India, and Japan, has increased access to sophisticated diagnostic technologies. Further, government initiatives and rising healthcare expenditures have also aided cancer screening programs, stimulating market growth. Moreover, the growing medical tourism industry in the region, specifically in countries with low-cost yet high-quality biopsy services, has also increased the growth in demand. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1–45%, Tier 2–30%, and Tier 3– 25% • By Designation: C-level–35%, Director-level–25% and Others–40% • By Region: North America–40%, Europe–20%, Asia Pacific–25%, Latin America- 10%, and Middle east and Africa-5% Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion. Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs. Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers. The major players operating in the biopsy device market are BD (US), Devicor medical products, Inc (US), Medtronic (Ireland), Cardinal Health (US), B.Braun SE ( Germany), Hologic,Inc (US), Olympus Corporation (Japan), Boston Scientific Corporation (US), FUJIFILM Corporation (Japan), Stryker (US), Teleflex Incorporated (US), CONMED Corporation (US), Merit Medical Systems (US), Johnson & Johnson Services,Inc. (US), Cook Group (US), MicroPort Scientific Corporation (China), Argon Medical Devices (US), INRAD, Inc (US), Summit Medical LLC (US), TransMed7, LLC (US), Dr. Japan Co., Ltd. (Japan), IZI Medical Products (US), Planmed Oy (Finland), Advin Health Care (India), Trivitron Healthcare (India). Research Coverage This report studies the biopsy device market based on product, type, technology, application end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions). Reasons to Buy the Report The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence. This report provides insights on the following pointers: • Analysis of Key divers (Rising prevalence of cancer), restraints (Increasing product recalls), Challenge (Technological advancements), opportunity (Underdeveloped healthcare infrastructure in emerging economies) • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the bbiopsy device market • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the biopsy device market • Market Development: Comprehensive information on lucrative emerging regions • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the biopsy devices market • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
目錄 Table of Contents
1 INTRODUCTION 42 1.1 STUDY OBJECTIVES 42 1.2 MARKET DEFINITION 42 1.3 STUDY SCOPE 43 1.3.1 MARKET SEGMENTATION & GEOGRAPHIC SPREAD 43 1.3.2 INCLUSIONS & EXCLUSIONS 44 1.4 YEARS CONSIDERED 45 1.5 CURRENCY CONSIDERED 45 1.6 STAKEHOLDERS 46 1.7 SUMMARY OF CHANGES 46 2 RESEARCH METHODOLOGY 47 2.1 RESEARCH DATA 47 2.1.1 SECONDARY DATA 48 2.1.1.1 Key data from secondary sources 49 2.1.2 PRIMARY DATA 49 2.1.2.1 Key data from primary sources 51 2.1.2.2 Key industry insights 51 2.2 MARKET SIZE ESTIMATION 52 2.3 ASSESSMENT OF MARKET SEGMENTS 56 2.4 ASSESSMENT OF GEOGRAPHIC SEGMENTS 56 2.5 MARKET BREAKDOWN & DATA TRIANGULATION 56 2.6 RESEARCH ASSUMPTIONS 57 2.7 RESEARCH LIMITATIONS 58 2.7.1 METHODOLOGY-RELATED LIMITATIONS 58 2.7.2 SCOPE-RELATED LIMITATIONS 58 2.8 RISK ASSESSMENT 58 3 EXECUTIVE SUMMARY 59 4 PREMIUM INSIGHTS 64 4.1 OPPORTUNITIES FOR PLAYERS IN BIOPSY DEVICES MARKET 64 4.2 NORTH AMERICA: BIOPSY DEVICES MARKET, BY END USER 65 4.3 BIOPSY DEVICES MARKET: GEOGRAPHIC SNAPSHOT 66 4.4 BIOPSY DEVICES MARKET: GEOGRAPHIC MIX 67 4.5 BIOPSY DEVICES MARKET: DEVELOPING VS. DEVELOPED MARKETS, 2024 VS. 2030 (USD MILLION) 67   5 MARKET OVERVIEW 68 5.1 INTRODUCTION 68 5.2 MARKET DYNAMICS 68 5.2.1 DRIVERS 69 5.2.1.1 Rising prevalence of cancer 69 5.2.1.2 Increasing preference for minimally invasive surgeries 69 5.2.1.3 Initiatives undertaken by governments and global health organizations 69 5.2.1.4 Increased number of hospitals and diagnostic centers 70 5.2.1.5 Improved reimbursement policies 70 5.2.2 RESTRAINTS 71 5.2.2.1 Increasing product recalls 71 5.2.2.2 High risk of infections 71 5.2.3 OPPORTUNITIES 71 5.2.3.1 Technological advancements 71 5.2.3.2 Growing investments in emerging economies 72 5.2.4 CHALLENGES 72 5.2.4.1 Underdeveloped healthcare infrastructure in emerging economies 72 5.3 INDUSTRY TRENDS 72 5.3.1 MINIMALLY INVASIVE PROCEDURES 73 5.3.2 ROBOTIC-ASSISTED BIOPSY DEVICES 73 5.3.3 LIQUID BIOPSY TECHNOLOGY 74 5.4 TECHNOLOGY ANALYSIS 74 5.4.1 KEY TECHNOLOGIES 74 5.4.1.1 Robotic-assisted biopsy devices 74 5.4.1.2 Optical biopsy technologies 75 5.4.1.3 Minimally invasive biopsy devices 75 5.4.2 COMPLEMENTARY TECHNOLOGIES 75 5.4.2.1 Imaging technologies 75 5.4.2.2 Tissue analysis technologies 76 5.4.2.3 Artificial intelligence 76 5.4.3 ADJACENT TECHNOLOGIES 77 5.4.3.1 Digital pathology and AI integration 77 5.4.3.2 Precision medicine tools 77 5.4.3.3 Advanced needle and probe technologies 77 5.5 PORTER’S FIVE FORCES ANALYSIS 78 5.5.1 THREAT FROM NEW ENTRANTS 78 5.5.2 BARGAINING POWER OF SUPPLIERS 78 5.5.3 BARGAINING POWER OF BUYERS 79 5.5.4 THREAT FROM SUBSTITUTES 79 5.5.5 INTENSITY OF COMPETITIVE RIVALRY 79   5.6 REGULATORY LANDSCAPE 80 5.6.1 REGULATIONS, BY REGION 80 5.6.1.1 North America 80 5.6.1.1.1 US 80 5.6.1.1.2 Canada 80 5.6.1.2 Europe 81 5.6.1.3 Asia Pacific 81 5.6.1.4 Latin America 81 5.6.1.5 Middle East & Africa 82 5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82 5.7 PATENT ANALYSIS 85 5.7.1 PATENT PUBLICATION TRENDS IN BIOPSY DEVICES MARKET 85 5.7.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 85 5.8 TRADE ANALYSIS 88 5.9 PRICING ANALYSIS 89 5.9.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY KEY PRODUCT 89 5.9.2 AVERAGE SELLING PRICE TREND OF BIOPSY DEVICES, BY REGION 90 5.10 KEY CONFERENCES & EVENTS 90 5.11 KEY STAKEHOLDERS & BUYING CRITERIA 91 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 91 5.11.2 BUYING CRITERIA 92 5.12 BIOPSY DEVICES MARKET: UNMET NEEDS/EXPECTATIONS OF END USERS 93 5.13 ECOSYSTEM ANALYSIS 94 5.14 CASE STUDY ANALYSIS 95 5.14.1 CASE STUDY 1: DEVICELAB COLLABORATED WITH CLINICAL EXPERTS TO IDENTIFY LIMITATIONS OF EXISTING BREAST BIOPSY PROCEDURES 95 5.14.2 CASE STUDY 2: RESEARCHERS AT UNIVERSITY OF TWENTE DESIGNED ROBOTIC SETUP AND SOFTWARE ARCHITECTURE TO ASSIST RADIOLOGISTS IN TARGETING MRI-DETECTED SUSPICIOUS TUMORS 96 5.14.3 CASE STUDY 3: RESEARCH TEAM DESIGNED FLEXIBLE ROBOTIC SYSTEM FOR BIOPSY SAMPLING APPLIED TO HUMAN CORPSES PLACED INSIDE PROTECTIVE BODY BAGS 96 5.15 SUPPLY CHAIN ANALYSIS 97 5.16 ADJACENT MARKET ANALYSIS 99 5.16.1 BREAST BIOPSY DEVICES MARKET 99 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 100 5.18 INVESTMENT & FUNDING SCENARIO 101 5.19 IMPACT OF AI ON BIOPSY DEVICES MARKET 101   6 BIOPSY DEVICES MARKET, BY PRODUCT 103 6.1 INTRODUCTION 104 6.2 NEEDLE-BASED BIOPSY INSTRUMENT 105 6.2.1 CORE NEEDLE BIOPSY 107 6.2.1.1 Core needle biopsy device 110 6.2.1.1.1 Semi-automatic 114 6.2.1.1.1.1 Need for balance of user control and automated functionality in procedures to drive market 114 6.2.1.1.2 Automatic 116 6.2.1.1.2.1 Demand for efficiency and accuracy in biopsy procedures to boost growth 116 6.2.1.2 Core needle biopsy needle 118 6.2.1.2.1 Disposable 121 6.2.1.2.1.1 Need for infection control and safety concerns to boost growth 121 6.2.1.2.2 Reusable 123 6.2.1.2.2.1 Cost-effectiveness of reusable core biopsy needles to drive market 123 6.2.2 FINE NEEDLE ASPIRATION BIOPSY 125 6.2.2.1 Innovations in needle design, including thinner profiles and improved tip configurations, to drive market 125 6.2.3 VACUUM-ASSISTED BIOPSY 128 6.2.3.1 Increasing need for early and accurate cancer detection to drive market 128 6.3 VISUALIZATION DEVICE/SYSTEM 131 6.3.1 RISING PREVALENCE OF CANCER AND OTHER CHRONIC CONDITIONS TO DRIVE DEMAND FOR VISUALIZATION DEVICE 131 6.4 BRUSH BIOPSY INSTRUMENT 133 6.4.1 PREFERENCE FOR MINIMALLY INVASIVE BIOPSY PROCEDURES TO BOOST MARKET 133 6.5 BIOPSY ACCESSORY 135 6.5.1 BIOPSY FORECEP 138 6.5.1.1 General biopsy forcep 141 6.5.1.1.1 Demand for minimally invasive procedures and precise diagnostics to surge growth 141 6.5.1.2 Hot biopsy forecep 143 6.5.1.2.1 Unique ability of hot biopsy forecep to cut and coagulate tissue to support growth 143 6.5.2 TISSUE MARKER 145 6.5.2.1 Rising cases of breast cancer to boost market growth 145 6.5.3 LOCALIZATION WIRE 147 6.5.3.1 Ability of localization wire to detect precise target locations to drive growth 147 6.5.4 OTHER ACCESSORIES 150 6.6 ROBOTIC BIOPSY DEVICE 151 6.6.1 RAPID DEVELOPMENT OF ROBOTIC BIOPSY DEVICES TO BOOST GROWTH 151 7 BIOPSY DEVICES MARKET, BY TECHNOLOGY 154 7.1 INTRODUCTION 155 7.2 ULTRASOUND-GUIDED BIOPSY 155 7.2.1 ULTRASOUND GUIDANCE ENHANCES SAFETY, MINIMIZES COMPLICATIONS, AND IMPROVES DIAGNOSTIC ACCURACY 155 7.3 STEREOTACTIC-GUIDED BIOPSY 157 7.3.1 NEED FOR EFFICIENT AND ACCURATE BIOPSY PROCEDURES TO SUPPORT MARKET GROWTH 157 7.4 OTHER TECHNOLOGIES 159 8 BIOPSY DEVICES MARKET, BY APPLICATION 162 8.1 INTRODUCTION 163 8.2 ONCOLOGY 164 8.2.1 BREAST CANCER 166 8.2.1.1 Increasing demand for early and accurate diagnosis to boost growth 166 8.2.2 SOFT TISSUE CANCER 168 8.2.2.1 Advancements in diagnostics and growing emphasis on cancer therapeutics to drive market 168 8.3 GASTROENTEROLOGY 170 8.3.1 RISING INCIDENCE OF GASTROINTESTINAL DISEASES TO DRIVE MARKET 170 8.4 BONE & BONE MARROW BIOPSY 172 8.4.1 RISING EMPHASIS ON BONE MARROW BIOPSIES TO SUPPORT MARKET GROWTH 172 8.5 OTHER APPLICATIONS 175 9 BIOPSY DEVICES MARKET, BY END USER 177 9.1 INTRODUCTION 178 9.2 HOSPITALS & BREAST CARE CENTERS 179 9.2.1 DEMAND FOR STATE-OF-THE-ART BIOPSY FACILITIES TO DRIVE MARKET 179 9.3 DIAGNOSTIC IMAGING CENTERS 182 9.3.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS TO SUPPORT MARKET GROWTH 182 9.4 AMBULATORY SURGICAL CENTERS 184 9.4.1 GROWING FOCUS ON AMBULATORY CARE TO DRIVE MARKET 184 9.5 OTHER END USERS 187 10 BIOPSY DEVICES MARKET, BY REGION 189 10.1 INTRODUCTION 190 10.2 NORTH AMERICA 193 10.2.1 MACROECONOMIC OUTLOOK 193 10.2.2 US 203 10.2.2.1 Growth in elderly population to drive market 203 10.2.3 CANADA 212 10.2.3.1 Rising government investments to drive growth 212 10.3 EUROPE 220 10.3.1 MACROECONOMIC OUTLOOK 220 10.3.2 GERMANY 229 10.3.2.1 Increasing prevalence of chronic diseases to propel market 229 10.3.3 UK 237 10.3.3.1 Initiatives by government to support market growth 237 10.3.4 FRANCE 245 10.3.4.1 Rising number of diagnostic imaging centers to drive market 245 10.3.5 ITALY 254 10.3.5.1 Availability of reimbursement coverage to support market growth 254 10.3.6 SPAIN 262 10.3.6.1 Increasing focus on cancer research to propel market 262 10.3.7 REST OF EUROPE 270 10.4 ASIA PACIFIC 278 10.4.1 MACROECONOMIC OUTLOOK 278 10.4.2 CHINA 289 10.4.2.1 Rapidly growing geriatric population to propel market 289 10.4.3 JAPAN 297 10.4.3.1 High adoption of advanced technologies to support market growth 297 10.4.4 INDIA 306 10.4.4.1 Rising prevalence of chronic diseases to drive market 306 10.4.5 AUSTRALIA 314 10.4.5.1 Increasing investments in research to provide opportunities for market growth 314 10.4.6 SOUTH KOREA 322 10.4.6.1 Presence of well-developed healthcare systems to propel market 322 10.4.7 REST OF ASIA PACIFIC 330 10.5 LATIN AMERICA 338 10.5.1 MACROECONOMIC OUTLOOK 339 10.5.2 BRAZIL 347 10.5.2.1 Favourable demographic conditions to drive market 347 10.5.3 MEXICO 356 10.5.3.1 Increased medical tourism and better government healthcare initiatives to drive market 356 10.5.4 REST OF LATIN AMERICA 364 10.6 MIDDLE EAST & AFRICA 372 10.6.1 MACROECONOMIC OUTLOOK 372 10.6.2 GCC COUNTRIES 381 10.6.2.1 Expansion of healthcare providers to drive growth 381 10.6.3 REST OF MIDDLE EAST & AFRICA 389 11 COMPETITIVE LANDSCAPE 397 11.1 OVERVIEW 397 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 397 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BIOPSY DEVICES MARKET 397 11.3 REVENUE ANALYSIS 399 11.4 MARKET SHARE ANALYSIS 399 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 402 11.5.1 STARS 402 11.5.2 EMERGING LEADERS 402 11.5.3 PERVASIVE PLAYERS 402 11.5.4 PARTICIPANTS 403 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 404 11.5.5.1 Company footprint 404 11.5.5.2 Region footprint 405 11.5.5.3 Product footprint 406 11.5.5.4 Technology footprint 407 11.5.5.5 Application footprint 408 11.5.5.6 End user footprint 409 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 410 11.6.1 PROGRESSIVE COMPANIES 410 11.6.2 RESPONSIVE COMPANIES 410 11.6.3 DYNAMIC COMPANIES 410 11.6.4 STARTING BLOCKS 410 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 411 11.7 COMPANY VALUATION & FINANCIAL METRICS 413 11.7.1 COMPANY VALUATION 413 11.7.2 FINANCIAL METRICS 413 11.8 BRAND/PRODUCT COMPARISON 414 11.9 COMPETITIVE SCENARIO 415 11.9.1 PRODUCT LAUNCHES & APPROVALS 415 11.9.2 DEALS 415 11.9.3 EXPANSIONS 416 12 COMPANY PROFILES 417 12.1 KEY PLAYERS 417 12.1.1 BD (BECTON, DICKINSON AND COMPANY) 417 12.1.1.1 Business overview 417 12.1.1.2 Products offered 419 12.1.1.3 Recent developments 427 12.1.1.3.1 Deals 427 12.1.1.4 MnM view 428 12.1.1.4.1 Key strengths 428 12.1.1.4.2 Strategic choices 428 12.1.1.4.3 Weaknesses & competitive threats 428 12.1.2 DEVICOR MEDICAL PRODUCTS, INC 429 12.1.2.1 Business overview 429 12.1.2.2 Products offered 430 12.1.2.3 Recent developments 433 12.1.2.3.1 Product launches & approvals 433 12.1.2.4 MnM view 433 12.1.2.4.1 Key strengths 433 12.1.2.4.2 Strategic choices 433 12.1.2.4.3 Weaknesses & competitive threats 434 12.1.3 MEDTRONIC 435 12.1.3.1 Business overview 435 12.1.3.2 Products offered 437 12.1.3.3 MnM view 438 12.1.3.3.1 Key strengths 438 12.1.3.3.2 Strategic choices 439 12.1.3.3.3 Weaknesses & competitive threats 439 12.1.4 CARDINAL HEALTH 440 12.1.4.1 Business overview 440 12.1.4.2 Products offered 442 12.1.4.3 MnM view 442 12.1.4.3.1 Key strengths 442 12.1.4.3.2 Strategic choices 442 12.1.4.3.3 Weaknesses & competitive threats 443 12.1.5 HOLOGIC, INC. 444 12.1.5.1 Business overview 444 12.1.5.2 Products offered 446 12.1.5.3 Recent developments 448 12.1.5.3.1 Deals 448 12.1.5.3.2 Other developments 449 12.1.5.4 MnM view 449 12.1.5.4.1 Key strengths 449 12.1.5.4.2 Strategic choices 449 12.1.5.4.3 Weaknesses & competitive threats 449 12.1.6 B. BRAUN SE 450 12.1.6.1 Business overview 450 12.1.6.2 Products offered 452 12.1.7 OLYMPUS CORPORATION 454 12.1.7.1 Business overview 454 12.1.7.2 Products offered 456 12.1.7.3 Recent developments 457 12.1.7.3.1 Deals 457 12.1.8 BOSTON SCIENTIFIC CORPORATION 458 12.1.8.1 Business overview 458 12.1.8.2 Products offered 460 12.1.9 FUJIFILM CORPORATION 462 12.1.9.1 Business overview 462 12.1.9.2 Products offered 464 12.1.10 STRYKER 465 12.1.10.1 Business overview 465 12.1.10.2 Products offered 466 12.1.11 TELEFLEX INCORPORATED 467 12.1.11.1 Business overview 467 12.1.11.2 Products offered 469 12.1.12 CONMED CORPORATION 470 12.1.12.1 Business overview 470 12.1.12.2 Products offered 472 12.1.13 MERIT MEDICAL SYSTEMS 474 12.1.13.1 Business overview 474 12.1.13.2 Products offered 476 12.1.14 JOHNSON & JOHNSON SERVICES, INC. 479 12.1.14.1 Business overview 479 12.1.14.2 Products offered 480 12.1.15 COOK GROUP 481 12.1.15.1 Business overview 481 12.1.15.2 Products offered 481 12.1.15.3 Recent developments 484 12.1.15.3.1 Product launches & approvals 484 12.2 OTHER PLAYERS 485 12.2.1 MICROPORT SCIENTIFIC CORPORATION 485 12.2.2 ARGON MEDICAL DEVICES 486 12.2.3 INRAD, INC. 487 12.2.4 SUMMIT MEDICAL LLC 488 12.2.5 TRANSMED7, LLC 489 12.2.6 DR. JAPAN CO., LTD. 490 12.2.7 IZI MEDICAL PRODUCTS 491 12.2.8 PLANMED OY 492 12.2.9 ADVIN HEALTH CARE 493 12.2.10 TRIVITRON HEALTHCARE 494   13 APPENDIX 495 13.1 DISCUSSION GUIDE 495 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 500 13.3 CUSTOMIZATION OPTIONS 502 13.4 RELATED REPORTS 502 13.5 AUTHOR DETAILS 503
圖表清單 List of Tables & Figures
TABLE 1 BIOPSY DEVICES MARKET: INCLUSIONS & EXCLUSIONS 44 TABLE 2 STANDARD CURRENCY CONVERSION RATE, 2019–2024 45 TABLE 3 RESEARCH ASSUMPTIONS 57 TABLE 4 PORTER’S FIVE FORCES ANALYSIS 78 TABLE 5 BIOPSY DEVICES UNDER FDA’S REGULATION 21 CFR 876.1075 80 TABLE 6 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82 TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83 TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83 TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84 TABLE 10 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84 TABLE 11 LIST OF PATENTS IN BIOPSY DEVICES MARKET, 2014−2024 87 TABLE 12 IMPORT DATA FOR HS CODE 901831-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2019–2023 (USD MILLION) 88 TABLE 13 EXPORT DATA FOR HS CODE 901831-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2019–2023 (USD MILLION) 88 TABLE 14 AVERAGE SELLING PRICE OF KEY PLAYERS, BY KEY PRODUCT, 2021–2023 (USD) 89 TABLE 15 AVERAGE SELLING PRICE TREND OF BIOPSY DEVICES, BY REGION, 2021–2023 (USD) 90 TABLE 16 BIOPSY DEVICES MARKET: KEY CONFERENCES & EVENTS, 2025 90 TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY END USERS 92 TABLE 18 KEY BUYING CRITERIA FOR KEY END USERS 92 TABLE 19 BIOPSY DEVICES MARKET: UNMET NEEDS 93 TABLE 20 BIOPSY DEVICES MARKET: EXPECTATIONS OF END USERS 93 TABLE 21 BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 104 TABLE 22 BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 104 TABLE 23 BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 105 TABLE 24 BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 105 TABLE 25 NEEDLE-BASED BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2021–2023 (USD MILLION) 106 TABLE 26 NEEDLE-BASED BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2024–2030 (USD MILLION) 107 TABLE 27 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 108 TABLE 28 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 108 TABLE 29 CORE NEEDLE BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 109 TABLE 30 CORE NEEDLE BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 110 TABLE 31 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 111 TABLE 32 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 111 TABLE 33 CORE NEEDLE BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 112 TABLE 34 CORE NEEDLE BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 113 TABLE 35 SEMI-AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 115 TABLE 36 SEMI-AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 116 TABLE 37 AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 117 TABLE 38 AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 118 TABLE 39 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 119 TABLE 40 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 119 TABLE 41 CORE NEEDLE BIOPSY NEEDLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 120 TABLE 42 CORE NEEDLE BIOPSY NEEDLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 121 TABLE 43 DISPOSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 122 TABLE 44 DISPOSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 123 TABLE 45 REUSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 124 TABLE 46 REUSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 125 TABLE 47 FINE NEEDLE ASPIRATION BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 126 TABLE 48 FINE NEEDLE ASPIRATION BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 127 TABLE 49 VACUUM-ASSISTED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 129 TABLE 50 VACUUM-ASSISTED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 130 TABLE 51 VISUALIZATION DEVICE/SYSTEM: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 132 TABLE 52 VISUALIZATION DEVICE/SYSTEM: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 133 TABLE 53 BRUSH BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2021–2023 (USD MILLION) 134 TABLE 54 BRUSH BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2024–2030 (USD MILLION) 135 TABLE 55 BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 136 TABLE 56 BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 136 TABLE 57 BIOPSY ACCESSORY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 137 TABLE 58 BIOPSY ACCESSORY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 138 TABLE 59 BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 139 TABLE 60 BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 139 TABLE 61 BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 140 TABLE 62 BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 141 TABLE 63 GENERAL BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 142 TABLE 64 GENERAL BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 143 TABLE 65 HOT BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 144 TABLE 66 HOT BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 145 TABLE 67 TISSUE MARKER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 146 TABLE 68 TISSUE MARKER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 147 TABLE 69 LOCALIZATION WIRE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 148 TABLE 70 LOCALIZATION WIRE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 149 TABLE 71 OTHER ACCESSORIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 150 TABLE 72 OTHER ACCESSORIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 151 TABLE 73 ROBOTIC BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 152 TABLE 74 ROBOTIC BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 153 TABLE 75 BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 155 TABLE 76 BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 155 TABLE 77 ULTRASOUND-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 156 TABLE 78 ULTRASOUND-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 157 TABLE 79 STEREOTACTIC-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 158 TABLE 80 STEREOTACTIC-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 159 TABLE 81 OTHER TECHNOLOGIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 160 TABLE 82 OTHER TECHNOLOGIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 161 TABLE 83 BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 163 TABLE 84 BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 163 TABLE 85 ONCOLOGY: BIOPSY DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION) 164 TABLE 86 ONCOLOGY: BIOPSY DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION) 164 TABLE 87 ONCOLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 165 TABLE 88 ONCOLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 166 TABLE 89 BREAST CANCER: BIOPSY DEVICES CANCER MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 167 TABLE 90 BREAST CANCER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 168 TABLE 91 SOFT TISSUE CANCER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 169 TABLE 92 SOFT TISSUE CANCER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 170 TABLE 93 GASTROENTEROLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 171 TABLE 94 GASTROENTEROLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 172 TABLE 95 BONE & BONE MARROW: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 173 TABLE 96 BONE & BONE MARROW: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 174 TABLE 97 OTHER APPLICATIONS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 175 TABLE 98 OTHER APPLICATIONS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 176 TABLE 99 BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 178 TABLE 100 BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 178 TABLE 101 HOSPITALS & BREAST CARE CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 180 TABLE 102 HOSPITALS & BREAST CARE CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 181 TABLE 103 DIAGNOSTIC IMAGING CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 183 TABLE 104 DIAGNOSTIC IMAGING CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 184 TABLE 105 AMBULATORY SURGICAL CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 185 TABLE 106 AMBULATORY SURGICAL CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 186 TABLE 107 OTHER END USERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 187 TABLE 108 OTHER END USERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 188 TABLE 109 BIOPSY DEVICES MARKET, BY REGION, 2021–2023 (USD MILLION) 191 TABLE 110 BIOPSY DEVICES MARKET, BY REGION, 2024–2030 (USD MILLION) 192 TABLE 111 BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2030 (THOUSAND UNITS) 193 TABLE 112 NORTH AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 194 TABLE 113 NORTH AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 195 TABLE 114 NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 195 TABLE 115 NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 195 TABLE 116 NORTH AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 196 TABLE 117 NORTH AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 196 TABLE 118 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 196 TABLE 119 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 197 TABLE 120 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 197 TABLE 121 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 197 TABLE 122 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 198 TABLE 123 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 198 TABLE 124 NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 198 TABLE 125 NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 199 TABLE 126 NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 199 TABLE 127 NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 199 TABLE 128 NORTH AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 200 TABLE 129 NORTH AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 200 TABLE 130 NORTH AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 200 TABLE 131 NORTH AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 201 TABLE 132 NORTH AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 201 TABLE 133 NORTH AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 201 TABLE 134 NORTH AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 202 TABLE 135 NORTH AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 202 TABLE 136 NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2030 (THOUSAND UNITS) 203 TABLE 137 US: MACRO-INDICATORS IMPACTING MARKET 204 TABLE 138 US: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 204 TABLE 139 US: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 205 TABLE 140 US: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 205 TABLE 141 US: BIOPSY DEVICES MARKET, BY NEEDLE BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 205 TABLE 142 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 206 TABLE 143 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 206 TABLE 144 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 206 TABLE 145 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 207 TABLE 146 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 207 TABLE 147 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 207 TABLE 148 US: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 208 TABLE 149 US: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 208 TABLE 150 US: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 208 TABLE 151 US: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 209 TABLE 152 US: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 209 TABLE 153 US: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 209 TABLE 154 US: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 210 TABLE 155 US: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 210 TABLE 156 US: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 210 TABLE 157 US: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 211 TABLE 158 US: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 211 TABLE 159 US: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 211 TABLE 160 CANADA: MACRO-INDICATORS IMPACTING MARKET 212 TABLE 161 CANADA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 212 TABLE 162 CANADA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 213 TABLE 163 CANADA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 213 TABLE 164 CANADA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 213 TABLE 165 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 214 TABLE 166 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 214 TABLE 167 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 214 TABLE 168 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 215 TABLE 169 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 215 TABLE 170 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 215 TABLE 171 CANADA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 216 TABLE 172 CANADA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 216 TABLE 173 CANADA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 216 TABLE 174 CANADA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 217 TABLE 175 CANADA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 217 TABLE 176 CANADA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 217 TABLE 177 CANADA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 218 TABLE 178 CANADA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 218 TABLE 179 CANADA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 218 TABLE 180 CANADA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 219 TABLE 181 CANADA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 219 TABLE 182 CANADA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 219 TABLE 183 EUROPE: BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 220 TABLE 184 EUROPE: BIOPSY DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 221 TABLE 185 EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 221 TABLE 186 EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 222 TABLE 187 EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 222 TABLE 188 EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 222 TABLE 189 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 223 TABLE 190 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 223 TABLE 191 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 223 TABLE 192 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 224 TABLE 193 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 224 TABLE 194 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 224 TABLE 195 EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 225 TABLE 196 EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 225 TABLE 197 EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 225 TABLE 198 EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 226 TABLE 199 EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 226 TABLE 200 EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 226 TABLE 201 EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 227 TABLE 202 EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 227 TABLE 203 EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 227 TABLE 204 EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 228 TABLE 205 EUROPE: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 228 TABLE 206 EUROPE: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 228 TABLE 207 EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2030 (THOUSAND UNITS) 229 TABLE 208 GERMANY: MACRO-INDICATORS IMPACTING MARKET 230 TABLE 209 GERMANY: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 230 TABLE 210 GERMANY: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 230 TABLE 211 GERMANY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 231 TABLE 212 GERMANY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 231 TABLE 213 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 231 TABLE 214 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 232 TABLE 215 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 232 TABLE 216 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 232 TABLE 217 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 233 TABLE 218 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 233 TABLE 219 GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 233 TABLE 220 GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 234 TABLE 221 GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 234 TABLE 222 GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 234 TABLE 223 GERMANY: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 235 TABLE 224 GERMANY: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 235 TABLE 225 GERMANY: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 235 TABLE 226 GERMANY: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 236 TABLE 227 GERMANY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 236 TABLE 228 GERMANY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 236 TABLE 229 GERMANY: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 237 TABLE 230 GERMANY: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 237 TABLE 231 UK: MACRO-INDICATORS IMPACTING MARKET 238 TABLE 232 UK: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 238 TABLE 233 UK: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 238 TABLE 234 UK: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 239 TABLE 235 UK: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 239 TABLE 236 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 239 TABLE 237 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 240 TABLE 238 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 240 TABLE 239 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 240 TABLE 240 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 241 TABLE 241 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 241 TABLE 242 UK: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 241 TABLE 243 UK: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 242 TABLE 244 UK: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 242 TABLE 245 UK: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 242 TABLE 246 UK: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 243 TABLE 247 UK: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 243 TABLE 248 UK: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 243 TABLE 249 UK: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 244 TABLE 250 UK: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 244 TABLE 251 UK: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 244 TABLE 252 UK: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 245 TABLE 253 UK: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 245 TABLE 254 FRANCE: MACRO-INDICATORS IMPACTING GROWTH 246 TABLE 255 FRANCE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 246 TABLE 256 FRANCE: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 247 TABLE 257 FRANCE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 247 TABLE 258 FRANCE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 247 TABLE 259 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 248 TABLE 260 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 248 TABLE 261 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 248 TABLE 262 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 249 TABLE 263 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 249 TABLE 264 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 249 TABLE 265 FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 250 TABLE 266 FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 250 TABLE 267 FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 250 TABLE 268 FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 251 TABLE 269 FRANCE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 251 TABLE 270 FRANCE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 251 TABLE 271 FRANCE: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 252 TABLE 272 FRANCE: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 252 TABLE 273 FRANCE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 252 TABLE 274 FRANCE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 253 TABLE 275 FRANCE: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 253 TABLE 276 FRANCE: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 253 TABLE 277 ITALY: MACRO-INDICATORS IMPACTING MARKET 254 TABLE 278 ITALY: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 254 TABLE 279 ITALY: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 255 TABLE 280 ITALY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 255 TABLE 281 ITALY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 255 TABLE 282 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 256 TABLE 283 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 256 TABLE 284 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 256 TABLE 285 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 257 TABLE 286 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 257 TABLE 287 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 257 TABLE 288 ITALY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 258 TABLE 289 ITALY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 258 TABLE 290 ITALY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 258 TABLE 291 ITALY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 259 TABLE 292 ITALY: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 259 TABLE 293 ITALY: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 259 TABLE 294 ITALY: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 260 TABLE 295 ITALY: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 260 TABLE 296 ITALY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 260 TABLE 297 ITALY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 261 TABLE 298 ITALY: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 261 TABLE 299 ITALY: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 261 TABLE 300 SPAIN: MACRO-INDICATORS IMPACTING MARKET 262 TABLE 301 SPAIN: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 262 TABLE 302 SPAIN: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 263 TABLE 303 SPAIN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 263 TABLE 304 SPAIN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 263 TABLE 305 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 264 TABLE 306 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 264 TABLE 307 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 264 TABLE 308 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 265 TABLE 309 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 265 TABLE 310 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 265 TABLE 311 SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 266 TABLE 312 SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 266 TABLE 313 SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 266 TABLE 314 SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 267 TABLE 315 SPAIN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 267 TABLE 316 SPAIN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 267 TABLE 317 SPAIN: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 268 TABLE 318 SPAIN: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 268 TABLE 319 SPAIN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 268 TABLE 320 SPAIN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 269 TABLE 321 SPAIN: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 269 TABLE 322 SPAIN: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 269 TABLE 323 REST OF EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 270 TABLE 324 REST OF EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 271 TABLE 325 REST OF EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 271 TABLE 326 REST OF EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 271 TABLE 327 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 272 TABLE 328 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 272 TABLE 329 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 272 TABLE 330 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 273 TABLE 331 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 273 TABLE 332 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 273 TABLE 333 REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 274 TABLE 334 REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 274 TABLE 335 REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 274 TABLE 336 REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 275 TABLE 337 REST OF EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 275 TABLE 338 REST OF EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 275 TABLE 339 REST OF EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 276 TABLE 340 REST OF EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 276 TABLE 341 REST OF EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 276 TABLE 342 REST OF EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 277 TABLE 343 REST OF EUROPE: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 277 TABLE 344 REST OF EUROPE: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 277 TABLE 345 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 280 TABLE 346 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 280 TABLE 347 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 281 TABLE 348 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 281 TABLE 349 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 282 TABLE 350 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 282 TABLE 351 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 282 TABLE 352 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 283 TABLE 353 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 283 TABLE 354 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 283 TABLE 355 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 284 TABLE 356 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 284 TABLE 357 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 284 TABLE 358 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 285 TABLE 359 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 285 TABLE 360 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 285 TABLE 361 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 286 TABLE 362 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 286 TABLE 363 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 286 TABLE 364 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 287 TABLE 365 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 287 TABLE 366 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 287 TABLE 367 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 288 TABLE 368 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 288 TABLE 369 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2030 (THOUSAND UNITS) 289 TABLE 370 CHINA: MACRO-INDICATORS IMPACTING MARKET 290 TABLE 371 CHINA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 290 TABLE 372 CHINA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 290 TABLE 373 CHINA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 291 TABLE 374 CHINA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 291 TABLE 375 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 291 TABLE 376 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 292 TABLE 377 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 292 TABLE 378 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 292 TABLE 379 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 293 TABLE 380 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 293 TABLE 381 CHINA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 293 TABLE 382 CHINA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 294 TABLE 383 CHINA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 294 TABLE 384 CHINA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 294 TABLE 385 CHINA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 295 TABLE 386 CHINA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 295 TABLE 387 CHINA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 295 TABLE 388 CHINA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 296 TABLE 389 CHINA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 296 TABLE 390 CHINA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 296 TABLE 391 CHINA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 297 TABLE 392 CHINA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 297 TABLE 393 JAPAN: MACRO-INDICATORS IMPACTING MARKET 298 TABLE 394 JAPAN: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 298 TABLE 395 JAPAN: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 299 TABLE 396 JAPAN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 299 TABLE 397 JAPAN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 299 TABLE 398 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 300 TABLE 399 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 300 TABLE 400 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 300 TABLE 401 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 301 TABLE 402 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 301 TABLE 403 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 301 TABLE 404 JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 302 TABLE 405 JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 302 TABLE 406 JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 302 TABLE 407 JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 303 TABLE 408 JAPAN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 303 TABLE 409 JAPAN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 304 TABLE 410 JAPAN: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 304 TABLE 411 JAPAN: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 305 TABLE 412 JAPAN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 305 TABLE 413 JAPAN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 305 TABLE 414 JAPAN: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 306 TABLE 415 JAPAN: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 306 TABLE 416 INDIA: MACRO-INDICATORS IMPACTING GROWTH 307 TABLE 417 INDIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 307 TABLE 418 INDIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 307 TABLE 419 INDIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 308 TABLE 420 INDIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 308 TABLE 421 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 308 TABLE 422 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 309 TABLE 423 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 309 TABLE 424 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 309 TABLE 425 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 310 TABLE 426 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 310 TABLE 427 INDIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 310 TABLE 428 INDIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 311 TABLE 429 INDIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 311 TABLE 430 INDIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 311 TABLE 431 INDIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 312 TABLE 432 INDIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 312 TABLE 433 INDIA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 312 TABLE 434 INDIA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 313 TABLE 435 INDIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 313 TABLE 436 INDIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 313 TABLE 437 INDIA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 314 TABLE 438 INDIA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 314 TABLE 439 AUSTRALIA: MACRO-INDICATORS IMPACTING MARKET 315 TABLE 440 AUSTRALIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 315 TABLE 441 AUSTRALIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 315 TABLE 442 AUSTRALIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 316 TABLE 443 AUSTRALIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 316 TABLE 444 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 316 TABLE 445 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 317 TABLE 446 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 317 TABLE 447 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 317 TABLE 448 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 318 TABLE 449 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 318 TABLE 450 AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 318 TABLE 451 AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 319 TABLE 452 AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 319 TABLE 453 AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 319 TABLE 454 AUSTRALIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 320 TABLE 455 AUSTRALIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 320 TABLE 456 AUSTRALIA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 320 TABLE 457 AUSTRALIA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 321 TABLE 458 AUSTRALIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 321 TABLE 459 AUSTRALIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 321 TABLE 460 AUSTRALIA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 322 TABLE 461 AUSTRALIA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 322 TABLE 462 SOUTH KOREA: MACRO-INDICATORS IMPACTING MARKET 323 TABLE 463 SOUTH KOREA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 323 TABLE 464 SOUTH KOREA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 323 TABLE 465 SOUTH KOREA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 324 TABLE 466 SOUTH KOREA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 324 TABLE 467 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 324 TABLE 468 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 325 TABLE 469 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 325 TABLE 470 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 325 TABLE 471 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 326 TABLE 472 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 326 TABLE 473 SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 326 TABLE 474 SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 327 TABLE 475 SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 327 TABLE 476 SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 327 TABLE 477 SOUTH KOREA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 328 TABLE 478 SOUTH KOREA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 328 TABLE 479 SOUTH KOREA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 328 TABLE 480 SOUTH KOREA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 329 TABLE 481 SOUTH KOREA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 329 TABLE 482 SOUTH KOREA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 329 TABLE 483 SOUTH KOREA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 330 TABLE 484 SOUTH KOREA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 330 TABLE 485 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 331 TABLE 486 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 331 TABLE 487 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 332 TABLE 488 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 332 TABLE 489 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 332 TABLE 490 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 333 TABLE 491 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 333 TABLE 492 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 333 TABLE 493 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 334 TABLE 494 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 334 TABLE 495 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 334 TABLE 496 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 335 TABLE 497 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 335 TABLE 498 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 335 TABLE 499 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 336 TABLE 500 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 336 TABLE 501 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 336 TABLE 502 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 337 TABLE 503 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 337 TABLE 504 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 337 TABLE 505 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 338 TABLE 506 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 338 TABLE 507 LATIN AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 339 TABLE 508 LATIN AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 339 TABLE 509 LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 340 TABLE 510 LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 340 TABLE 511 LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 340 TABLE 512 LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 341 TABLE 513 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 341 TABLE 514 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 341 TABLE 515 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 342 TABLE 516 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 342 TABLE 517 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 342 TABLE 518 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 343 TABLE 519 LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 343 TABLE 520 LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 343 TABLE 521 LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 344 TABLE 522 LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 344 TABLE 523 LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 344 TABLE 524 LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 345 TABLE 525 LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 345 TABLE 526 LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 345 TABLE 527 LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 346 TABLE 528 LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 346 TABLE 529 LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 346 TABLE 530 LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 347 TABLE 531 LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2030 (THOUSAND UNITS) 347 TABLE 532 BRAZIL: MACRO-INDICATORS IMPACTING MARKET 348 TABLE 533 BRAZIL: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 348 TABLE 534 BRAZIL: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 349 TABLE 535 BRAZIL: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 349 TABLE 536 BRAZIL: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 349 TABLE 537 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 350 TABLE 538 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 350 TABLE 539 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 350 TABLE 540 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 351 TABLE 541 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 351 TABLE 542 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 351 TABLE 543 BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 352 TABLE 544 BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 352 TABLE 545 BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 352 TABLE 546 BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 353 TABLE 547 BRAZIL: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 353 TABLE 548 BRAZIL: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 353 TABLE 549 BRAZIL: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 354 TABLE 550 BRAZIL: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 354 TABLE 551 BRAZIL: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 354 TABLE 552 BRAZIL: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 355 TABLE 553 BRAZIL: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 355 TABLE 554 BRAZIL: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 355 TABLE 555 MEXICO: MACRO-INDICATORS IMPACTING MARKET 356 TABLE 556 MEXICO: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 357 TABLE 557 MEXICO: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 357 TABLE 558 MEXICO: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 357 TABLE 559 MEXICO: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 358 TABLE 560 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 358 TABLE 561 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 358 TABLE 562 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 359 TABLE 563 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 359 TABLE 564 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 359 TABLE 565 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 360 TABLE 566 MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 360 TABLE 567 MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 360 TABLE 568 MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 361 TABLE 569 MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 361 TABLE 570 MEXICO: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 361 TABLE 571 MEXICO: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 362 TABLE 572 MEXICO: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 362 TABLE 573 MEXICO: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 362 TABLE 574 MEXICO: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 363 TABLE 575 MEXICO: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 363 TABLE 576 MEXICO: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 363 TABLE 577 MEXICO: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 364 TABLE 578 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 364 TABLE 579 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 365 TABLE 580 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 365 TABLE 581 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 365 TABLE 582 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 366 TABLE 583 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 366 TABLE 584 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 366 TABLE 585 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 367 TABLE 586 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 367 TABLE 587 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 367 TABLE 588 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 368 TABLE 589 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 368 TABLE 590 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 368 TABLE 591 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 369 TABLE 592 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 369 TABLE 593 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 369 TABLE 594 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 370 TABLE 595 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 370 TABLE 596 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 370 TABLE 597 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 371 TABLE 598 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 371 TABLE 599 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 371 TABLE 600 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 372 TABLE 601 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 372 TABLE 602 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 373 TABLE 603 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 373 TABLE 604 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 374 TABLE 605 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 374 TABLE 606 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 374 TABLE 607 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 375 TABLE 608 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 375 TABLE 609 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 375 TABLE 610 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 376 TABLE 611 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 376 TABLE 612 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 376 TABLE 613 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 377 TABLE 614 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 377 TABLE 615 MIDDLE EAST &AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 377 TABLE 616 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 378 TABLE 617 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 378 TABLE 618 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 378 TABLE 619 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 379 TABLE 620 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 379 TABLE 621 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 379 TABLE 622 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 380 TABLE 623 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 380 TABLE 624 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2030 (THOUSAND UNITS) 381 TABLE 625 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 382 TABLE 626 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 382 TABLE 627 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 382 TABLE 628 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 383 TABLE 629 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 383 TABLE 630 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 383 TABLE 631 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 384 TABLE 632 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 384 TABLE 633 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 384 TABLE 634 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 385 TABLE 635 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 385 TABLE 636 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 385 TABLE 637 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 386 TABLE 638 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 386 TABLE 639 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 386 TABLE 640 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 387 TABLE 641 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 387 TABLE 642 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 387 TABLE 643 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 388 TABLE 644 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 388 TABLE 645 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 388 TABLE 646 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 389 TABLE 647 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 389 TABLE 648 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 390 TABLE 649 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 390 TABLE 650 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 390 TABLE 651 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 391 TABLE 652 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 391 TABLE 653 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 391 TABLE 654 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 392 TABLE 655 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 392 TABLE 656 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 392 TABLE 657 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 393 TABLE 658 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 393 TABLE 659 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 393 TABLE 660 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 394 TABLE 661 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 394 TABLE 662 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 394 TABLE 663 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 395 TABLE 664 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 395 TABLE 665 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 395 TABLE 666 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 396 TABLE 667 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 396 TABLE 668 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 396 TABLE 669 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BIOPSY DEVICES MARKET 397 TABLE 670 BIOPSY DEVICES MARKET: DEGREE OF COMPETITION 400 TABLE 671 BIOPSY DEVICES MARKET: REGION FOOTPRINT 405 TABLE 672 BIOPSY DEVICES MARKET: PRODUCT FOOTPRINT 406 TABLE 673 BIOPSY DEVICES MARKET: TECHNOLOGY FOOTPRINT 407 TABLE 674 BIOPSY DEVICES MARKET: APPLICATION FOOTPRINT 408 TABLE 675 BIOPSY DEVICES MARKET: END USER FOOTPRINT 409 TABLE 676 BIOPSY DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 411 TABLE 677 BIOPSY DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION 412 TABLE 678 BIOPSY DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 415 TABLE 679 BIOPSY DEVICES MARKET: DEALS, JANUARY 2021–JANUARY 2025 415 TABLE 680 BIOPSY DEVICES MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2025 416 TABLE 681 BD (BECTON, DICKINSON AND COMPANY): COMPANY OVERVIEW 417 TABLE 682 BD (BECTON, DICKINSON AND COMPANY): PRODUCTS OFFERED 419 TABLE 683 BD (BECTON, DICKINSON AND COMPANY): DEALS, JANUARY 2021–JANUARY 2025 427 TABLE 684 DEVICOR MEDICAL PRODUCTS, INC: COMPANY OVERVIEW 429 TABLE 685 DEVICOR MEDICAL PRODUCTS, INC: PRODUCTS OFFERED 430 TABLE 686 DEVICOR MEDICAL PRODUCTS, INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 433 TABLE 687 MEDTRONIC: COMPANY OVERVIEW 435 TABLE 688 MEDTRONIC: PRODUCTS OFFERED 437 TABLE 689 CARDINAL HEALTH: COMPANY OVERVIEW 440 TABLE 690 CARDINAL HEALTH: PRODUCTS OFFERED 442 TABLE 691 HOLOGIC, INC.: COMPANY OVERVIEW 444 TABLE 692 HOLOGIC, INC: PRODUCTS OFFERED 446 TABLE 693 HOLOGIC, INC: DEALS, JANUARY 2021–JANUARY 2025 448 TABLE 694 B. BRAUN SE: COMPANY OVERVIEW 450 TABLE 695 B. BRAUN SE: PRODUCTS OFFERED 452 TABLE 696 OLYMPUS CORPORATION: COMPANY OVERVIEW 454 TABLE 697 OLYMPUS CORPORATION: PRODUCTS OFFERED 456 TABLE 698 OLYMPUS CORPORATION: DEALS, JANUARY 2021–JANUARY 2025 457 TABLE 699 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 458 TABLE 700 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 460 TABLE 701 FUJIFILM CORPORATION: COMPANY OVERVIEW 462 TABLE 702 FUJIFILM CORPORATION: PRODUCTS OFFERED 464 TABLE 703 STRYKER: COMPANY OVERVIEW 465 TABLE 704 STRYKER: PRODUCTS OFFERED 466 TABLE 705 TELEFLEX INCORPORATED: COMPANY OVERVIEW 467 TABLE 706 TELEFLEX INCORPORATED: PRODUCTS OFFERED 469 TABLE 707 CONMED CORPORATION: COMPANY OVERVIEW 470 TABLE 708 CONMED CORPORATION: PRODUCTS OFFERED 472 TABLE 709 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW 474 TABLE 710 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED 476 TABLE 711 MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 478 TABLE 712 MERIT MEDICAL SYSTEMS: DEALS, JANUARY 2021–JANUARY 2025 478 TABLE 713 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW 479 TABLE 714 JOHNSON & JOHNSON SERVICES INC.: PRODUCTS OFFERED 480 TABLE 715 COOK GROUP: COMPANY OVERVIEW 481 TABLE 716 COOK GROUP: PRODUCTS OFFERED 481 TABLE 717 COOK GROUP: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 484 FIGURE 1 RESEARCH DESIGN 47 FIGURE 2 PRIMARY SOURCES 50 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 52 FIGURE 4 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 53 FIGURE 5 TOP-DOWN APPROACH 53 FIGURE 6 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55 FIGURE 7 BIOPSY DEVICES MARKET: CAGR PROJECTIONS 55 FIGURE 8 DATA TRIANGULATION METHODOLOGY 57 FIGURE 9 BIOPSY DEVICES MARKET, BY PRODUCT, 2024 VS. 2030 (USD MILLION) 59 FIGURE 10 BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024 VS. 2030 (USD MILLION) 60 FIGURE 11 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024 VS. 2030 (USD MILLION) 60 FIGURE 12 BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024 VS. 2030 (USD MILLION) 61 FIGURE 13 BIOPSY DEVICES MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION) 61 FIGURE 14 BIOPSY DEVICES MARKET, BY END USER, 2024 VS. 2030 (USD MILLION) 62 FIGURE 15 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 63 FIGURE 16 RISING CASES OF CANCER TO DRIVE GLOBAL ADOPTION OF BIOPSY DEVICES 64 FIGURE 17 US AND HOSPITALS & BREAST CARE CENTERS SEGMENT ACCOUNTED FOR SIGNIFICANT SHARE IN 2023 65 FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 66 FIGURE 19 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 67 FIGURE 20 DEVELOPING MARKET SEGMENT TO REGISTER HIGHER GROWTH THAN DEVELOPED MARKET SEGMENT BY 2030 67 FIGURE 21 BIOPSY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 68 FIGURE 22 TRENDS IN BIOPSY DEVICES MARKET 73 FIGURE 23 BIOPSY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 79 FIGURE 24 NUMBER OF PATENTS PUBLISHED, 2014–2025 85 FIGURE 25 TOP TEN PATENT OWNERS FOR BIOPSY DEVICES, 2014−2025 86 FIGURE 26 TOP APPLICANTS FOR BIOPSY DEVICES, 2014−2025 86 FIGURE 27 AVERAGE SELLING PRICE OF KEY PLAYERS, BY KEY PRODUCT, 2021–2023 (USD) 89 FIGURE 28 AVERAGE SELLING PRICE TREND OF BIOPSY DEVICES, BY REGION, 2021–2023 (USD) 90 FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY END USERS 91 FIGURE 30 KEY BUYING CRITERIA FOR KEY END USERS 92 FIGURE 31 BIOPSY DEVICES MARKET: ECOSYSTEM ANALYSIS 94 FIGURE 32 BIOPSY DEVICES MARKET: SUPPLY CHAIN ANALYSIS 98 FIGURE 33 REVENUE SHIFT FOR BIOPSY DEVICES MARKET 100 FIGURE 34 INVESTMENT & FUNDING SCENARIO, 2019–2023 (USD MILLION) 101 FIGURE 35 USE OF AI/GEN AI IN BIOPSY PROCEDURES 102 FIGURE 36 NORTH AMERICA: BIOPSY DEVICES MARKET SNAPSHOT 194 FIGURE 37 ASIA PACIFIC: BIOPSY DEVICES MARKET SNAPSHOT 279 FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS, 2021–2023 (USD MILLION) 399 FIGURE 39 MARKET SHARE ANALYSIS, 2023 400 FIGURE 40 RANKING OF KEY PLAYERS IN BIOPSY DEVICES MARKET, 2023 402 FIGURE 41 BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 403 FIGURE 42 BIOPSY DEVICES MARKET: COMPANY FOOTPRINT 404 FIGURE 43 BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 411 FIGURE 44 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 413 FIGURE 45 EV/EBITDA OF KEY PLAYERS 413 FIGURE 46 BIOPSY DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 414 FIGURE 47 BD (BECTON, DICKINSON AND COMPANY): COMPANY SNAPSHOT (2024) 418 FIGURE 48 DEVICOR MEDICAL PRODUCTS, INC: COMPANY SNAPSHOT (2023) 430 FIGURE 49 MEDTRONIC: COMPANY SNAPSHOT (2024) 436 FIGURE 50 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 441 FIGURE 51 HOLOGIC, INC.: COMPANY SNAPSHOT (2024) 445 FIGURE 52 B. BRAUN SE: COMPANY SNAPSHOT (2023) 451 FIGURE 53 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2024) 455 FIGURE 54 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023) 459 FIGURE 55 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2024) 463 FIGURE 56 STRYKER: COMPANY SNAPSHOT (2023) 466 FIGURE 57 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2023) 468 FIGURE 58 CONMED CORPORATION: COMPANY SNAPSHOT (2023) 471 FIGURE 59 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2023) 475 FIGURE 60 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2023) 480

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們